These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31603796)

  • 41. ICan: an integrated co-alteration network to identify ovarian cancer-related genes.
    Zhou Y; Liu Y; Li K; Zhang R; Qiu F; Zhao N; Xu Y
    PLoS One; 2015; 10(3):e0116095. PubMed ID: 25803614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Learning common and specific patterns from data of multiple interrelated biological scenarios with matrix factorization.
    Zhang L; Zhang S
    Nucleic Acids Res; 2019 Jul; 47(13):6606-6617. PubMed ID: 31175825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diverse somatic mutation patterns and pathway alterations in human cancers.
    Kan Z; Jaiswal BS; Stinson J; Janakiraman V; Bhatt D; Stern HM; Yue P; Haverty PM; Bourgon R; Zheng J; Moorhead M; Chaudhuri S; Tomsho LP; Peters BA; Pujara K; Cordes S; Davis DP; Carlton VE; Yuan W; Li L; Wang W; Eigenbrot C; Kaminker JS; Eberhard DA; Waring P; Schuster SC; Modrusan Z; Zhang Z; Stokoe D; de Sauvage FJ; Faham M; Seshagiri S
    Nature; 2010 Aug; 466(7308):869-73. PubMed ID: 20668451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multi-omics peripheral and core regions of cancer.
    Wang B; Dong X; Hu J; Gao L
    NPJ Syst Biol Appl; 2022 Nov; 8(1):47. PubMed ID: 36446819
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel gene signatures for prognosis prediction in ovarian cancer.
    Bao M; Zhang L; Hu Y
    J Cell Mol Med; 2020 Sep; 24(17):9972-9984. PubMed ID: 32666642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Network-Based Isoform Quantification with RNA-Seq Data for Cancer Transcriptome Analysis.
    Zhang W; Chang JW; Lin L; Minn K; Wu B; Chien J; Yong J; Zheng H; Kuang R
    PLoS Comput Biol; 2015 Dec; 11(12):e1004465. PubMed ID: 26699225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patient-specific data fusion defines prognostic cancer subtypes.
    Yuan Y; Savage RS; Markowetz F
    PLoS Comput Biol; 2011 Oct; 7(10):e1002227. PubMed ID: 22028636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Driver network as a biomarker: systematic integration and network modeling of multi-omics data to derive driver signaling pathways for drug combination prediction.
    Huang L; Brunell D; Stephan C; Mancuso J; Yu X; He B; Thompson TC; Zinner R; Kim J; Davies P; Wong STC
    Bioinformatics; 2019 Oct; 35(19):3709-3717. PubMed ID: 30768150
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CPAS: a trans-omics pathway analysis tool for jointly analyzing DNA copy number variations and mRNA expression profiles data.
    Zhang F; Xiao X; Hao J; Wang S; Wen Y; Guo X
    J Biomed Inform; 2015 Feb; 53():363-6. PubMed ID: 25546614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cancer Target Gene Screening: a web application for breast cancer target gene screening using multi-omics data analysis.
    Kim HY; Choi HJ; Lee JY; Kong G
    Brief Bioinform; 2020 Mar; 21(2):663-675. PubMed ID: 30698638
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MOSClip: multi-omic and survival pathway analysis for the identification of survival associated gene and modules.
    Martini P; Chiogna M; Calura E; Romualdi C
    Nucleic Acids Res; 2019 Aug; 47(14):e80. PubMed ID: 31049575
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparative study of multi-omics integration tools for cancer driver gene identification and tumour subtyping.
    Sathyanarayanan A; Gupta R; Thompson EW; Nyholt DR; Bauer DC; Nagaraj SH
    Brief Bioinform; 2020 Dec; 21(6):1920-1936. PubMed ID: 31774481
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The panoramic picture of pepsinogen gene family with pan-cancer.
    Shen S; Li H; Liu J; Sun L; Yuan Y
    Cancer Med; 2020 Dec; 9(23):9064-9080. PubMed ID: 33067881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FGMD: A novel approach for functional gene module detection in cancer.
    Jin D; Lee H
    PLoS One; 2017; 12(12):e0188900. PubMed ID: 29244808
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis.
    Tong L; Mitchel J; Chatlin K; Wang MD
    BMC Med Inform Decis Mak; 2020 Sep; 20(1):225. PubMed ID: 32933515
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel personalized pathway-based metabolomics models reveal key metabolic pathways for breast cancer diagnosis.
    Huang S; Chong N; Lewis NE; Jia W; Xie G; Garmire LX
    Genome Med; 2016 Mar; 8(1):34. PubMed ID: 27036109
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The R implementation of the CRAN package PATHChange, a tool to study genetic pathway alterations in transcriptomic data.
    Fontoura CA; Castellani G; Mombach JC
    Comput Biol Med; 2016 Nov; 78():76-80. PubMed ID: 27665533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New Algorithm and Software (BNOmics) for Inferring and Visualizing Bayesian Networks from Heterogeneous Big Biological and Genetic Data.
    Gogoshin G; Boerwinkle E; Rodin AS
    J Comput Biol; 2017 Apr; 24(4):340-356. PubMed ID: 27681505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
    Mo W; Ding Y; Zhao S; Zou D; Ding X
    PLoS One; 2020; 15(11):e0241924. PubMed ID: 33170908
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    Concolino P; Gelli G; Rizza R; Costella A; Scambia G; Capoluongo E
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.